1.0GCC Regulatory Affairs Pharma Summithttps://pramagcc.com/raadmin@ra2025https://pramagcc.com/ra/author/adminra2025/Sylvie Meillerais - GCC Regulatory Affairs Pharma Summitrich600338<blockquote class="wp-embedded-content" data-secret="dtHUITJviR"><a href="https://pramagcc.com/ra/member/sylvie-meillerais/">Sylvie Meillerais</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://pramagcc.com/ra/member/sylvie-meillerais/embed/#?secret=dtHUITJviR" width="600" height="338" title="“Sylvie Meillerais” — GCC Regulatory Affairs Pharma Summit" data-secret="dtHUITJviR" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://pramagcc.com/ra/wp-includes/js/wp-embed.min.js
</script>
https://pramagcc.com/ra/wp-content/uploads/2024/10/25.-Sylvie-Meillerais.png11271126Sylvie Meillerais started her career in research, in academia and industry, and moved to regulatory policy through positions in Brussels pharmaceutical trade associations, including EFPIA. She then joined MSD as Director Global Regulatory Policy in June 2015; in her current role, her expertise and knowledge of the European pharmaceutical environment serves to drive regulatory policy […]